These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9654693)

  • 1. Adverse events after oral vaccination against cholera with CVD103-HgR.
    Wiedermann G; Kollaritsch H; Jeschko E; Kundi M; Herzog C; Wegmüller B
    Wien Klin Wochenschr; 1998 May; 110(10):376-8. PubMed ID: 9654693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults.
    Valera R; García HM; Jidy MD; Mirabal M; Armesto MI; Fando R; García L; Fernández R; Año G; Cedré B; Ramírez M; Bravo L; Serrano T; Palma S; González D; Miralles F; Medina V; Nuñez F; Plasencia Y; Martínez JC; Mandarioti A; Lugones J; Rodríguez BL; Moreno A; González D; Baro M; Solis RL; Sierra G; Barbera R; Domínguez F; Gutiérrez C; Kouri G; Campa C; Menéndez J
    Vaccine; 2009 Nov; 27(47):6564-9. PubMed ID: 19720365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
    Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
    Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized placebo controlled human volunteer trial of a live oral cholera vaccine VA1.3 for safety and immune response.
    Mahalanabis D; Ramamurthy T; Nair GB; Ghosh A; Shaikh S; Sen B; Thungapathra M; Ghosh RK; Pazhani GP; Nandy RK; Jana S; Bhattacharya SK
    Vaccine; 2009 Jul; 27(35):4850-6. PubMed ID: 19523608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous vaccination in Japanese travelers.
    Mizuno Y; Kano S; Urashima M; Genka I; Kanagawa S; Kudo K
    Travel Med Infect Dis; 2007 Mar; 5(2):85-9. PubMed ID: 17298913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral cholera vaccine--for whom, when, and why?
    Topps MH
    Travel Med Infect Dis; 2006 Jan; 4(1):38-42. PubMed ID: 16887724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statement on oral cholera vaccination.
    Can Commun Dis Rep; 1998 Dec; 24():1-4. PubMed ID: 9868845
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of fecal-orally transmitted diseases in travelers through an oral anticholeric vaccine (WC/rBS).
    Gabutti G; Aquilina M; Cova M; Giuffrida S; Lizioli A; Protano D; Scrivano F; Tomasi A; Cucchi A; Cavallaro A;
    J Prev Med Hyg; 2012 Dec; 53(4):199-203. PubMed ID: 23469588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
    Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
    Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Travellers' compliance with the use of an oral cholera vaccine].
    Cucchi A; Cova M; Merciadri GV; Serenelli C; Ghiselli G; Buriani O; Gabutti G
    Ig Sanita Pubbl; 2010; 66(4):409-18. PubMed ID: 21132038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
    Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
    Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
    Murray J; McFarland DA; Waldman RJ
    Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can oral cholera vaccination play a role in controlling a cholera outbreak?
    Calain P; Chaine JP; Johnson E; Hawley ML; O'Leary MJ; Oshitani H; Chaignat CL
    Vaccine; 2004 Jun; 22(19):2444-51. PubMed ID: 15193408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
    Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
    Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for CVD 103-HgR as an effective single-dose oral cholera vaccine.
    Jackson SS; Chen WH
    Future Microbiol; 2015; 10(8):1271-81. PubMed ID: 26228388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand.
    Phares CR; Date K; Travers P; Déglise C; Wongjindanon N; Ortega L; Bhuket PR
    Vaccine; 2016 Jan; 34(1):128-33. PubMed ID: 26549363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.
    Vu DT; Hossain MM; Nguyen DS; Nguyen TH; Rao MR; Do GC; Naficy A; Nguyen TK; Acosta CJ; Deen JL; Clemens JD; Dang DT
    J Health Popul Nutr; 2003 Dec; 21(4):304-8. PubMed ID: 15043004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled field trial of the effectiveness of cholera and cholera El Tor vaccines in the Philippines.
    Azurin JC; Cruz A; Pesigan TP; Alvero M; Camena T; Suplido R; Ledesma L; Gomez CZ
    Bull World Health Organ; 1967; 37(5):703-27. PubMed ID: 5300874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled field trial of plain and aluminium hydroxide-adsorbed cholera vaccines in Surabaya, Indonesia, during 1973--75.
    Saroso JS; Bahrawi W; Witjaksono H; Budiarso RL; Brotowasisto ; Bencić Z; Dewitt WE; Gomez CZ
    Bull World Health Organ; 1978; 56(4):619-27. PubMed ID: 365388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of safety and effects on the oral whole cell/recombinant B subunit cholera vaccine in university students and workers].
    Shi NM; Luo FJ; Li SM; Bai YH; Qu Y; Song X
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(3):192-5. PubMed ID: 20356556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.